Richmond, VA, United States of America

Kaleo, Inc.


USPTO Granted Patents = 79

% Expired Patents = 11.4



Trademarks = 6

Forward Citations = 1,398

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Evan Thomas Edwards (75 out of 101 patents)

silverMedal Eric S Edwards (75 out of 103 patents)

bronzeMedal Paul F Meyers (66 out of 96 patents)

4 Mark J Licata (57 out of 96 patents)

5 David A Weinzierl (21 out of 28 patents)

6 Frank E Blondino (14 out of 15 patents)

7 T Spencer Williamson (8 out of 11 patents)

8 Michael J Roe (6 out of 6 patents)

9 Kai R Worrell (5 out of 13 patents)

10 Glen L Kelley (5 out of 7 patents)

11 George McGee Perkins (2 out of 11 patents)

12 Samuel Jefferson Briggs (2 out of 2 patents)

13 Eugene Johannes Van Wyk (2 out of 2 patents)

14 Mitchell Frederick Burke (2 out of 2 patents)

15 Eric William Scammell (2 out of 2 patents)


Core Competencies:
Medicament Delivery Devices
Prefilled Syringe
Auto-Injectors
Wireless Connectivity
Compliance Tracking
Lyophilized Medicament
Opioid Antagonists
Multi-Chamber Container
Self-Administration
Medical Injector
Event Detection
Electronic Circuit System

79 patents:

Kaleo, Inc. is a leading healthcare technology company that specializes in creating and delivering life-saving therapies. Our mission is to empower patients and improve outcomes through innovative medical solutions. With a focus on auto-injector systems, we aim to provide safe, accessible, and effective treatments for acute conditions such as allergies and opioid overdoses. Visit our website to learn more about our cutting-edge products and commitment to making a positive impact in the healthcare industry.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Kaleo, Inc.
79 Patents

#13 in Richmond, VA

#78 in Virginia

#4,681 in US

#9,549 in the World

Richmond, VA (US)
Richmond, VA, United States of America
Forward Citations = 1,398

18 inventors:

Please report any incorrect information to [email protected]
Loading…